Objective
RAMPART aims to address the significant clinical challenge of tumor resistance to anticancer therapies, a key factor contributing to
treatment failure and decreased patient survival, particularly in Head and Neck Squamous Cell Carcinoma (HNSCC). The project’s
primary objective is to develop a label-free, nondestructive and rapid methodology using Raman and multimodal imaging to identify
biomarkers of tumor resistance, by monitoring the biochemical responses of ex vivo patient-derived tumor slices to both immunotherapy
and radiotherapy.
To do so, RAMPART will employ cutting-edge Raman spectroscopy, including both spontaneous (SR) and a multimodal microscope
(SRS-TPEF-SHG), to perform high-resolution biomolecular mapping and imaging of patient-derived tumor samples. This approach
allows for precise detection of biomolecular changes within the tumor microenvironment (TME), offering a comprehensive
understanding of the factors driving therapy resistance. The project will be conducted at Politecnico di Milano (main host), and two
secondments at Jena University Hospital (UKJ) and Johns Hopkins University (JHU), where I will prepare patient-derived
HNSCC slices.
The relevance of RAMPART lies in its potential to significantly enhance clinical decision-making in HNSCC oncology,
advancing the state-of-the-art in tumor evaluation, with label-free and nondestructive approaches for biomolecular tumor imaging.
By establishing a protocol for the early detection of resistance biomarkers, the project will enable rapid, personalized treatment
strategies tailored to individual patients, driving to decision-making time of 5-7 days. Additionally, the insights gained into tumor
heterogeneity and the TME will contribute to a more profound understanding of their roles in treatment outcomes. The project’s
findings are expected to potentially impact on the field of precision medicine, ultimately improving survival rates and quality
of life for patients with HNSCC.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
- natural sciencesphysical sciencesopticsmicroscopy
- medical and health sciencesclinical medicineoncology
- medical and health sciencesbasic medicineimmunologyimmunotherapy
- natural sciencesphysical sciencesopticsspectroscopy
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Programme(s)
- HORIZON.1.2 - Marie Skłodowska-Curie Actions (MSCA) Main Programme
Funding Scheme
HORIZON-TMA-MSCA-PF-EF - HORIZON TMA MSCA Postdoctoral Fellowships - European FellowshipsCoordinator
20133 Milano
Italy